Vitruvian Partners
Vitruvian Partners reported 8 stocks worth $113M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are HNGE (38.6%), MQ (25.7%) and XMTR (13.3%). Compared with Q2 2026, the fund opened new positions in MQ, trimmed HNGE, XMTR and CARG and sold out of MQ.
Latest filing: what Vitruvian Partners did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() HNGE Hinge Health Inc | $43.8M | 38.6% | 450K | −57K (−11%) | 6 of 8 | |
| 2 | ![]() MQ Marqeta Inc-A | $29.1M | 25.7% | 1.7M | New position | 1 of 8 | |
| 3 | ![]() XMTR Xometry Inc | $15M | 13.3% | 146K | −35K (−19%) | 8 of 8 | |
| 4 | ![]() GLBE Global E Online Ltd | $8.4M | 7.4% | 210K | No change | 7 of 8 | |
| 5 | ![]() CARG Cargurus Inc | $6.9M | 6.0% | 220K | −130K (−37%) | 8 of 8 | |
| 6 | ![]() MXCT Maxcyte Inc | $5.6M | 5.0% | 5M | No change | 8 of 8 | |
| 7 | ![]() WSE Wise Group PLC Ord Shs Class A | $3.2M | 2.8% | 281K | No change | 2 of 8 | |
| 8 | ![]() RXST Rxsight Inc | $1.4M | 1.2% | 279K | No change | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() MQ Marqeta Inc | $111M | 6.9M |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 13, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Vitruvian Partners 13F FAQ
What does Vitruvian Partners own?
Vitruvian Partners reported 8 stocks worth $113M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are HNGE (38.6%), MQ (25.7%) and XMTR (13.3%). The table above lists every position in the filing (the top 10 without an account).
What did Vitruvian Partners buy and sell in Q3 2026?
Compared with Q2 2026: 1 new positions, 0 added to, 3 trimmed and 1 sold out. New positions include MQ. It sold all of MQ.
When will Vitruvian Partners file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Vitruvian Partners's portfolio worth?
The Q3 2026 filing reports $113M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.







